Company Profile

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1870.05-134.8 (-6.72 % )
PREV CLOSE (Rs.) 2004.85
OPEN PRICE (Rs.) 2005.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1864.90 (185 )
VOLUME 109272
TODAY'S LOW / HIGH (Rs.)1852.75 2035.90
52 WK LOW / HIGH (Rs.)1796.75 3302.55
NSE1871.20 -131 (-6.54 % )
PREV CLOSE(Rs.) 2002.20
OPEN PRICE (Rs.) 2009.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1871.20 (1290 )
VOLUME 1722823
TODAY'S LOW / HIGH(Rs.) 1851.30 2038.50
52 WK LOW / HIGH (Rs.)1794.9 3307.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.02
Dividend Yield(%) 1.50
TTM EPS (Rs.) -43.35
P/E Ratio 0.00
Book Value (Rs.) 1176.18
Face Value (Rs.) 2
MCap (Rs. in Mn) 371853.02
Price/Earning (TTM) -50.88
Price/Sales (TTM) 10.13
Price/Book (MRQ) 1.59
PAT Margin (%) 15.73
ROCE (%) 5.75
Incorporation Year : 1947

Management Info :

Ajay G Piramal - Chairman - Managing Director

Registered Office :

Address : Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone : 022 3802 3000/4000

Website : www.piramal.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
17Jun06-17-2019$Piramal Enterprises sells entire direct investment of Shriram Transport Finance Piramal Enterprises sells en

Piramal Enterprises has sold its entire direct investment of 9.96% in the fully paid-up share capital of Shriram Transport Finance Company to third party investors on the floor of the stock exchange. 

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises has sold its entire direct investment of 9...
17Jun06-17-2019$Piramal Enterprises informs about disclosure Piramal Enterprises informs

Piramal Enterprises has informed about disclosure under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Piramal Enterprises has informed about disclosure under Securit..
12Jun06-12-2019$Piramal Enterprises gets nod to raise Rs 200 crore Piramal Enterprises gets nod

Piramal Enterpriseshas received approval the allotment of 2,000 secured, rated, redeemable Non-Convertible Debentures each having a Face Value of Rs 10,00,000, aggregating to Rs 200 crore on private placement basis. These Non-Convertible Debentures are proposed to be listed on Wholesale Debt Market segment of NSE. The Administrative Committee of the Board of Directors of the Company at its meeting held on June 12, 2019 has approved for the same.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterpriseshas received approval the allotment of 2,000..
12Jun06-12-2019$Piramal Enterprises informs about committee meeting Piramal Enterprises informs

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Enterprises has informed that at the Meeting of Administrative Committee of the Board of Directors of the Company held today, the Committee approved the allotment of 2,000 secured, rated, redeemable Non-Convertible Debentures each having a Face Value of Rs 1,000,000, aggregating to Rs 200 Crores on private placement basis. These Non-Convertible Debentures are proposed to be listed on Wholesale Debt Market segment of NSE.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the Securities and Exchange Board..
12Jun06-12-2019$Reliance Industries, Sakar Healthcare and South Indian Bank to see some action today Reliance Industries, Sakar H

Reliance Industries (RIL) and BP have sanctioned the MJ project (also known as D55) in Block KG D6, offshore the east coast of India. MJ is the third of three new projects in the Block KG D6 integrated development plan and its approval follows sanctions for the development of ‘R-Series’ deep-water gas field in June 2017 and for the Satellites cluster in April 2018.

Sakar Healthcare has initiated the process of business expansion with anti-cancer (oncology) drugs. The project has been perceived and articulated to get operational by 2021. The market dynamics, encouraging growth opportunity and in-house competency have been the decisive factors to opt for this therapeutic class of drugs.

South Indian Bank is planning to raise funds in Indian / foreign currency by issue of debt securities. The Board of Directors of the bank at its meeting to be held on June 15, 2019 to consider the same.

Eicher Motors and Volvo Group’s joint venture (JV) -- VE Commercial Vehicles has called for fiscal measures to boost growth in the heavily-taxed auto sector. The JV Company also plans to invest Rs 700 crore this fiscal, a part of which will go into adding capacity etc.

KDDL’s subsidiary -- Ethos has shifted the operations of its store at Unit no. 08, First Floor, Pavilion Mall in Pune to Unit no. 32-B, Ground Floor, Pavilion Mall. The area of the above store is 1694 sq. ft. The aforesaid is a multi - brand store. The total number of stores as on date remains the same i.e. 48 only.

Piramal Enterprises has received an approval for the issue of secured, rated, redeemable Non-Convertible Debentures (NCDs) on private placement basis up to Rs 200 crore each having a face value of Rs 10,00,000, along with an option to retain oversubscription of up to Rs 100 crore, the total issue size aggregating and not exceeding Rs 300 crore. These Non-Convertible Debentures are proposed to be listed on Wholesale Debi Markel segment of NSE.

Avenue Supermarts has raised funds through issuance of Commercial Paper (CP) worth Rs 100 crore. The company has issued CP on June 11, 2019 and it will mature on September 09, 2019. The rating agency, CRISIL has assigned ‘A1+’ rating to the instrument.

Reliance Industries (RIL) and BP have sanctioned the MJ project..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit-622-8619.8
Gross Profit -811.7 -7915.8
Operating Profit 4029.621241.7
Net Sales 10126.136714
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 3948.60 (2.48%)
M.Cap ( in Cr)
6554.43
Astrazeneca Pharma I (BSE)
 1886.40 (3.32%)
M.Cap ( in Cr)
4716.00
Dr. Reddys Lab (BSE)
 2590.00 (1.54%)
M.Cap ( in Cr)
43021.65
Torrent Pharma (BSE)
 1512.15 (0.97%)
M.Cap ( in Cr)
25586.90
IOL Chem & Pharma (BSE)
 192.05 (3.73%)
M.Cap ( in Cr)
1092.52
Shareholding Pattern More
FI/BANKS/INSURANCE 5.93 %
PROMOTERS 49.7 %
NON-INSTITUTION 17.17 %
MUTUAL FUNDS/UTI 0.33 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested